Join CBSET and our partner CILcare at the Safety Pharmacology Society Northeast Regional Meeting, April 28, from 8:00 AM to 4:00 PM, at Takeda Cambridge, 125 Binney Street, Cambridge, Massachusetts.
This year’s meeting theme, “Beyond the Core Battery - Explore and Discover” will push past the traditional boundaries of the core battery to discuss changes in the regulatory landscape, advanced tissue chips and in-vitro models, translational platforms, non-traditional experimental species, as well as non-life-threatening adverse endpoints that impact a drug’s implementation.
CBSET Study Director, Donald Hodges is a co-organizer for the meeting, CBSET will be exhibiting at the meeting, and both CBSET and CILcare will be presenting.
Ototoxicity: global burden & preclinical auditory safety study cases, Lise Byelyayeva, CILCare, France
Young Investigator Presentation 1: Histopathology: key biomarkers in the evaluation of ototoxicity, Carolanne Coyat, CILcare, France
Swine, the Other Tox Species Rami Tzafriri, PhD, Director of Research and Innovation, CBSET
HEAR THIS! Potential Therapeutics for COVID-19 Should Be Tested for Auditory Safety
by Wahid Awad, PhD, Chief Business Officer, CILcare and Michael Naimark, Director of Business Development, CBSET, Inc.
World Pharma Today, August 24, 2020
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
Published in World Pharma Today, November 1, 2017